LOXL1 Polymorphism in Pseudoexfoliation Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01515735|
Recruitment Status : Unknown
Verified January 2012 by Samsung Medical Center.
Recruitment status was: Recruiting
First Posted : January 24, 2012
Last Update Posted : January 24, 2012
|Condition or disease|
To evaluate the association profiles of the lysyl oxidase-like 1 gene polymorphisms with pseudoexfoliation syndrome in the Korean population, peripheral blood sampling will be done from the patients with pseudoexfoliation.
And genotypes of the three single nucleotide polymorphisms of lysyl oxidase-like 1 gene , rs1048661, rs3825942, rs2165241 were analyzed by direct sequencing.
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Observational Model:||Case Control|
|Official Title:||Evaluation of LOXL1 Polymorphism in Pseudoexfoliation Syndrome in the Korean Population|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2012|
The study group composted of the patients with pseudoexfoliation syndrome
- Genotypes of the three single nucleotide polymorphisms of LOXL1 (rs1048661, rs3825942, rs2165241) [ Time Frame: about 1 year (when all patients were recruited) ]Genotypes of the three single nucleotide polymorphisms of LOXL1 were analyzed by direct sequencing, after obtained from the peripheral blood sampling from patients.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01515735
|Contact: Changwon Kee, M.D., Ph.D.||email@example.com|
|Korea, Republic of|
|Samsung medical center||Recruiting|
|Seoul, Korea, Republic of, 135710|
|Contact: Changwon Kee, M.D., Ph.D 82-2-3410-3564 firstname.lastname@example.org|
|Principal Investigator: changwon Kee, M.D., Ph.D|
|Study Chair:||Changwon Kee, M.D., PhD||Samsung Medical Center|